Elbit Imaging Ltd. announced its results for the second quarter of 2013. Consolidated Income revenues and gains for the three months period ended June 30, 2013 amounted to NIS 124 million ($ 34 million) compared to NIS 132 million in the ...
Tags: Apparel, Accessories
Israel-based ultrasound technology provider InSightec has received the approval from Health Canada for its ExAblate system designed to treat uterine fibroids and pain palliation of bone metastases non-invasively. The third generation ...
Tags: InSightec, ExAblate System
InSightec has received approval from the Chinese Food and Drug Administration (CFDA) for its ExAblate system designed to treat uterine fibroids non-invasively. This system uses high intensity focused ultrasound energy to destroy the ...
Tags: InSightec, Ultrasound System
The European Union has granted CE mark approval to InSightec's transcranial focused ultrasound system for the treatment of essential tremor, tremor dominant Parkinson's disease and neuropathic pain. The non-invasive ExAblate Neuro ...
Tags: transcranial focused ultrasound system, Parkinson's disease
InSightec Image Guided Treatment, a subsidiary of Elbit Medical Technologies, has signed a memorandum of understanding (MOU) with GE Healthcare. Under the MOU, GE Healthcare will invest $27.5m in Insightec, reports globes.co.il. ...